Condition: Head & Neck Cancer · Sponsor: Tang-Du Hospital
This is a prospective,single-arm,Phase II clinical study to designed to evaluate the efficancy and safety of nimotuzumab Combined with Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
This description comes directly from the study's public registry record.
Zhao DaQing · 86+13720528990 · zhaodq430@163.com
Always discuss trial participation with your own doctor first.
| Tangdu Hospital, Air Force Medical University, Xi'an 710038, Shaanxi Province, China | Shanxi, Province, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07353723